4/A//SEC Filing
Hammoud Tarek 4/A
Accession 0001104659-22-050539
CIK 0001868912other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 8:57 PM ET
Size
8.3 KB
Accession
0001104659-22-050539
Insider Transaction Report
Form 4/AAmended
Enfusion, Inc.ENFN
Hammoud Tarek
Director10% Owner
Transactions
- Disposition to Issuer
Common Units of Enfusion Ltd. LLC
2021-10-25$15.89/sh−1,545,746$24,569,633→ 11,870,386 total(indirect: See Footnote)→ Class A Common Stock (1,545,746 underlying)
LRA Ventures, LLC
Other
Transactions
- Disposition to Issuer
Common Units of Enfusion Ltd. LLC
2021-10-25$15.89/sh−1,545,746$24,569,633→ 11,870,386 total(indirect: See Footnote)→ Class A Common Stock (1,545,746 underlying)
Footnotes (3)
- [F1]The common units of Enfusion Ltd. LLC (the "Common Units"), and the corresponding shares of Class B common stock are exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis with the Issuer having the ability to elect to pay cash in lieu of issuing Class A common stock.
- [F2]This amount represents the $17.00 initial public offering price per share of common stock of the Issuer, less the underwriting discount of $1.105 per share.
- [F3]These Common Units are held by LRA Ventures, LLC. Tarek Hammoud is the sole manager of LRA Ventures, LLC, an estate planning vehicle of which Mr. Hammoud is the sole manager. Mr. Hammoud may be deemed to have dispositive power over the Common Units held by LRA Ventures, LLC. Mr. Hammoud disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Documents
Issuer
Enfusion, Inc.
CIK 0001868912
Entity typeother
Related Parties
1- filerCIK 0001880790
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 8:57 PM ET
- Size
- 8.3 KB